Raloxifene Liquid

Raloxifene is a selective estrogen receptor modulators, which are known for blocking estrogen from attaching to breast tissue. This allows for the potential to treat and decrease the risk of developing breast cancer in females.

Raloxifene liquid thus has the ability to occupy the estrogen receptor sites on the breast tissue, leaving no space for the incoming, growth-stimulating estrogens to attach to, effectively reducing breast volume. Multiple studies are investigating these claims. In one study, a 3-to-9 month Raloxifene treatment course decreased gynecomastia by up to 86%.

Raloxifene
CAS Number	84449-90-1
Molar Mass	473,584 g·mol−1
Chemical Formula	C28H27NO4S
IUPAC Name	[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone